Rznomics
Search results
Scope
Date
~
-
Bio & PharmaSouth Korea’s Rznomics inks $1.3 bn out-licensing deal with Eli Lilly
Rznomics Inc., a South Korean RNA therapeutics developer, has signed an agreement worth more than $1.3 billion with US pharmaceutical giant Eli Lill...
May 16, 2025 (Gmt+09:00)
1
Latest News
- 1 Shinhan Securities acquires strategic stake in Vietnam’s top trading platform FireAnt
- 2 Bird flu in Brazil hikes wholesale chicken prices in Korea
- 3 Vietnam, gateway for SK Group’s global renewable energy push
- 4 Hanwha Philly Shipyard to localize LNG builds, expand capacity
- 5 Bain Capital sells 6% stake in Korea’s Classys via block deal for $163 million
